OliX

팝업닫기

Refusal of Unauthorized Collection of E-mail Addresses

We do not allow the unauthorized collection of e-mail addresses listed on our website.Persons engaging in unauthorized collection with e-mail address collection programs or other technical devices will be subject to criminal prosecution in accordance with the Act on Information & Communications Network Utilization and Information Protection.

Contact Us

form mail list
Name *
Tel *	- -
E-mail *	@
Subject *
Contents
File1
File2
Spam Check*	* 왼쪽의 자동등록방지 코드를 입력하세요.

Consent to Collect and Use Personal Information

I agree to the use of personal information collected from myself or other legitimate sources.

Information collected : Name, Phone number, E-mail, Message
Purpose of collection and use : conducting certain services or activities including but not limited to replying to inquiries and maintaining business records.
Period of retention and use : Personal information is to be discarded after the purpose of collection and use has been achieved.

- Personal Information shall be discarded without delay once the purpose of collection and use has been achieved; provided however that, if an obligation to retain such information exists under applicable law(s), the information shall be retained for a period of time as required by such law(s).
- Even prior to the purpose of use and collection being achieved, personal information may be discarded upon request via email sent to olixpharma@olixpharma.com. Please note, however, that your use of the services herein may be limited.

※ You have the right not to consent to the collection and use of your personal information, in which event your use of the services may be limited.

I agree to the terms and conditions.

Platform Technology

RNAi platform development

Lead compound discovery

Pulmonology / Neurology

Pharmacological research on OliX RNAi compounds for respiratory and neurological diseases

Ophthalmology

Pharmacological research on OliX RNAi compounds for ocular diseases

Animal Research

Testing efficacy of oligonucleotide therapeutics using animal models

Analytics

Develop analytical methods for therapeutic candidates to determine purity and stability in support of nonclinical and clinical studies

PK/TK

Develop bioanalytical methods to quantitate therapeutic candidates in biological matrices for pharmacokinetic and toxicokinetic (PK/TK) studies

CMC

Manage manufacturing, analytics and quality of therapeutic candidates

Toxicology

Conduct safety evaluation and toxicokinetic assessment of therapeutic candidates through nonclinical studies

Clinical

Establish clinical development plans for therapeutic candidates and conduct clinical studies

Management

Business Management

Purchasing

General Affairs

Facility Management

Contingency Planning

Planning

Budget/Performance Management

Mid to Long-term Business Goals/Strategy Planning

Accounting & Finance

Make official announcements about business contents, financial condition, business performance etc.

Stabilize Internal Accounting Control System

IT

IT Infrastructure Management

IT Helpdesk

Human Resources

HR Policy/System Establishment, Organization/Job Design

Recruitment/HR Management

Performance Management, Employee Welfare

HR Development

Legal Affairs

Prevent, respond, handle legal disputes

Provide risk management and compliance support

Develop IP strategies for core technologies

Quality Assurance(QA)

Verify pharmaceutical R&D processes and results

Ensure product to meet the established quality standards

Business Development

Develop/Maintain Client Relationships

Execute Licensing Agreements

New Business/Strategy Planning

Communications

Provide investment information in a timely manner to increase company value

Promote management activities and establish internal/external communication strategies

Create positive corporate culture through various in-house activities and employee education

Home
IR

IR

Stock Information

Stock Information

2023/12/01 14:39:01 (장중)

· Stock Information

- A226950
  OliX
- Now 13,910
- Change ▲160(1.16%)
- Volume 23,572
- Value 326,732,710

Current	13,750	Upper Limit		17,870
High	14,000	Lower Limit		9,630
Low	13,700	Par Value		500
PER	0.00	52 week	High	26,800
Listed Stocks	16,009,759	52 week	Low	12,900

· Price

Ask Size	A&B	Bid Size
87	13,960
20	13,950
12	13,930
3	13,920
5	13,910
	13,880	92
	13,870	158
	13,860	215
	13,850	157
	13,840	733
127	Total	1,355

· Hourly Prices

Time	Close(￦)	Change	Ask Price	Bid Price	Volume
14:37:30	13,910	160	13,910	13,880	200
14:35:10	13,890	140	13,900	13,880	10
14:31:20	13,880	130	13,890	13,880	5
14:31:00	13,880	130	13,890	13,880	23
14:28:50	13,890	140	13,890	13,880	1
14:27:10	13,890	140	13,890	13,880	11
14:25:50	13,880	130	13,890	13,880	3
14:21:40	13,880	130	13,890	13,880	260
14:20:50	13,880	130	13,900	13,880	65
14:16:30	13,880	130	13,900	13,880	167

· Daily Prices

Date	Close(￦)	Change	Current	High	Low	Volume	Value
23/12/01	13,910	160	13,750	14,000	13,700	23,572	326,732,710
23/11/30	13,750	180	13,570	13,840	13,570	24,785	339,396,220
23/11/29	13,570	530	14,100	14,100	13,500	107,928	1,476,024,610
23/11/28	14,100	280	14,380	14,380	13,950	23,124	325,218,660
23/11/27	14,380	260	13,950	14,980	13,800	67,247	950,831,050
23/11/24	14,120	230	14,370	14,370	13,920	37,385	524,762,600
23/11/23	14,350	450	13,830	14,430	13,730	53,508	761,479,000
23/11/22	13,900	200	14,100	14,100	13,800	28,293	393,296,590
23/11/21	14,100	70	14,030	14,140	13,970	23,775	334,372,680
23/11/20	14,030	430	13,600	14,080	13,600	41,114	573,533,030